Identification of patients at risk for preeclampsia with the use of uterine artery Doppler velocimetry and copeptin

References

• Vargas-Rojas MI, Solleiro-Villavicencio H, Soto-Vega E. Th1, Th2, Th17 and Treg levels in umbilical cord blood in preeclampsia. J Matern Fetal Neonatal Med 2016;29:1642–5.
   PubMed Web of Science ®Google Scholar
• Meads CA, Cnossen JS, Meher S, et al. Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modeling. Health Technol Assess 2008;12:1–270.
   Web of Science ®Google Scholar
• Salomon LJ, Benattar C, Audibert F. Severe preeclampsia is associated with high inhibin-A levels and abnormal leptin levels at 7 to 13 weeks into pregnancy. Am J Obstet Gynecol 2003;189:1517–22.
   PubMed Web of Science ®Google Scholar
• Nickel CH, Bingisser R, Morgenthaler NG. The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department. BMC Med 2012;10:7.
   PubMed Web of Science ®Google Scholar
• Dunser MW, Wenzel V, Mayr AJ, et al. Management of vasodilatory shock: defining the role of arginine vasopressin. Drugs 2003;63:237–56.
   PubMed Web of Science ®Google Scholar
• McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev. 2007;87:873–904.
   PubMed Web of Science ®Google Scholar
• Struck J, Morgenthaler NG, Bergmann A. Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients. Peptides 2005;26:2500–4.
   PubMed Web of Science ®Google Scholar
• Darzy KH, Dixit KC, Shalet SM, et al. Circadian secretion pattern of copeptin, the C-terminal vasopressin precursor fragment. Clin Chem 2010;56:1190–1.
   PubMed Web of Science ®Google Scholar
• Zulfikaroglu E, Islimye M, Tonguc EA, et al. Circulating levels of copeptin, a novel biomarker in pre-eclampsia. J Obstet Gynaecol Res 2011;37:1198–202.
   PubMed Web of Science ®Google Scholar
• Yeung EH, Liu A, Mills JL, et al. Increased levels of copeptin before clinical diagnosis of pre-eclampsia. Hypertension 2014;64:1362–7.
   PubMed Web of Science ®Google Scholar
• Santillan MK, Santillan DA, Scroggins SM, et al. Vasopressin in preeclampsia: a novel very early human pregnancy biomarker and clinically relevant mouse model. Hypertension 2014;64:852–9.
   PubMed Web of Science ®Google Scholar
• Li N, Ghosh G, Gudmundsson S. Uterine artery Doppler in high-risk pregnancies at 23–24 gestational weeks is of value in predicting adverse outcome of pregnancy and selecting cases for more intense surveillance. Acta Obstet Gynecol Scand 2014;93:1276–81.
   PubMed Web of Science ®Google Scholar
• Afrakhteh M, Moeini A, Taheri MS, et al. Uterine Doppler velocimetry of the uterine arteries in the second and third trimesters for the prediction of gestational outcome. Rev Bras Ginecol Obstet 2014;36:35–9.
   PubMedGoogle Scholar
• Wright D, Syngelaki A, Akolekar R, et al. Competing risks model in screening for preeclampsia by maternal characteristics and medical history. Am J Obstet Gynecol 2015;213:62.e1–10.
   PubMed Web of Science ®Google Scholar
• Snijders RJ, Nicolaides KH. Fetal biometry at 14–40 weeks' gestation. Ultrasound Obstet Gynecol 1994;4:34–48.
   PubMed Web of Science ®Google Scholar
• Brown MA, Lindheimer MD, de Swiet M, et al. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20:IX–XIV.
   PubMed Web of Science ®Google Scholar
• Albaiges G, Missfelder-Lobos H, Lees C, et al. One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks’ gestation. Obstet Gynecol 2000;96:559–64.
   PubMed Web of Science ®Google Scholar
• Birdir C, Janssen K, Stanescu AD, et al. Maternal serum copeptin, MR-proANP and procalcitonin levels at 11–13 weeks gestation in the prediction of preeclampsia. Arch Gynecol Obstet 2015;292:1033–42.
   PubMed Web of Science ®Google Scholar
• Saleem U, Khaleghi M, Morgenthaler NG, et al. Plasma carboxy-terminal provasopressin (copeptin): a novel marker of insulin resistance and metabolic syndrome. J Clin Endocrinol Metab 2009;94:2558–64.
   PubMed Web of Science ®Google Scholar
• Foda AA, Abdel Aal IA. Maternal and neonatal copeptin levels at cesarean section and vaginal delivery. Eur J Obstet Gynecol Reprod Biol 2012;165:215–18.
   PubMed Web of Science ®Google Scholar
• Wellmann S, Benzing J, Fleischlin S, et al. Cardiovascular biomarkers in preeclampsia at triage. Fetal Diagn Ther 2014;36:202–7.
   PubMed Web of Science ®Google Scholar
• Adali E, Yildizhan R, Kolusari A, et al. Increased visfatin and leptin in pregnancies complicated by preeclampsia. J Matern Fetal Neonatal Med 2009;1:1–7.
   Google Scholar
• Prajapati SR, Maitra N. Prediction of pre-eclampsia by a combination of maternal history, uterine artery Doppler, and mean arterial pressure (a prospective study of 200 cases). J Obstet Gynaecol India 2013;63:32–6.
   PubMedGoogle Scholar
• Bhattacharyya SK, Kundu S, Kabiraj SP. Prediction of preeclampsia by midtrimester uterine artery Doppler velocimetry in high-risk and low-risk women. J Obstet Gynaecol India 2012;62:297–300.
   PubMedGoogle Scholar
• Pietryga M, Brazert J, Wender-Ozegowska E, et al. Placental Doppler velocimetry in gestational diabetes mellitus. J Perinat Med 2006;34:108–10.
   PubMed Web of Science ®Google Scholar
• Stampalija T, Gyte GM, Alfirevic Z. Utero-placental Doppler ultrasound for improving pregnancy outcome. Cochrane Database Syst Rev 2010;9:CD008363.
   PubMed Web of Science ®Google Scholar
• Fadigas C, Guerra L, Garcia-Tizon Larroca S, et al. Prediction of small for gestational age neonates: screening by uterine artery Doppler and mean arterial pressure at 19–24 weeks. Ultrasound Obstet Gynecol 2015;45:715–21.
   PubMed Web of Science ®Google Scholar
• Enhörning S, Wang TJ, Nilsson PM, et al. Plasma copeptin and the risk of diabetes mellitus. Circulation 2010;121:2102–8.
   PubMed Web of Science ®Google Scholar
• Abbasi A, Corpeleijn E, Meijer E, et al. Sex differences in the association between plasma copeptin and incident type 2 diabetes: the prevention of renal and vascular endstage disease (PREVEND) study. Diabetologia 2012;55:1963–70.
   PubMed Web of Science ®Google Scholar
• Hansen AT, Sandager P, Uldbjerg N, et al. Copeptin is not a useful biomarker for small-for-gestational-age: a case control study. Scand J Clin Lab Invest 2014;74:687–92.
   PubMed Web of Science ®Google Scholar